|
|||||
|
|
| 万拉法新治疗躯体化障碍临床研究 | |
| 引用本文： | 鞠贵平. 万拉法新治疗躯体化障碍临床研究[J]. 中国民康医学, 2003, 15(10): 590-590,594 |
| 作者姓名： | 鞠贵平 |
| 作者单位： | 江苏省扬州五台山医院,江苏,扬州,225003 |
| 摘 要： | 目的：评价万拉法新对躯体化障碍的疗效和副反应。方法：对68例躯体化障碍患者随机分为万拉法新组和多虑平组，治疗6周，用汉密尔顿抑郁量表(HAMD)、不良反应量表(TESS)评定疗效和副反应。结果：万拉法新与多虑平疗效相当，起效比多虑平快，没有严重的副反应。结论：万拉法新治疗躯体化障碍疗效确切、起效快、副反应小。 |
| 关 键 词： | 万拉法新 治疗 躯体化障碍 临床研究 副反应 |
| 文章编号： | 1672-0369(2003)10-0590-02 |
A study of venlafaxine in the treatment of somatization disorder |
|
| JU Gui-ping. A study of venlafaxine in the treatment of somatization disorder[J]. medical journal of chinese peoples health, 2003, 15(10): 590-590,594 | |
| Authors: | JU Gui-ping |
| Abstract: | Objective: To compare the efficacy and side effect of venlafax ine and doxepin in the treatment of somatization disorder. Method: 68 pa tients of Somati zation disorder were randomly assigned to venlafaxine group and doxepin group f or 6 weeks. Effects and side reactions were evaluated with HAMD and TESS before and after treatment. Results: The therapeutic efficacy in venlaf axine group was similar to that in doxepin. The efficacy in venlafaxine group went out faster i n beginning, venlafaxine had fewer side effects. Conclusion: Venl afaxine is effec five in the treatment of somatization disorder and produces fewer side effects. |
| Keywords: | Somatization disorder Venlafaxine Doxopin. |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |